Company Data
TransCode Therapeutics Inc.
Ticker
RNAZ
Current Price
$7.62 -18.68%
Market Cap
$5.3M
Price Target
Refer to Report
Volume
70.5K
52wk Range
$2.66 - $66.33
Overview
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.